Skip to main content
. 2019 Feb;5(1):24–26. doi: 10.15420/cfr.2018.35.1

Table 2: Assessment of Eligibility for Advanced Heart Failure Treatment Versus Indications for Referral to a Specialised Heart Failure Centre.

Assessment of Eligibility for Advanced Heart Failure Therapy Indications for Referral to a Specialised Heart Failure Centre

  • NYHA class

  • INTERMACS level

  • NT-proBNP levels

  • Electrolytes, bilirubin

  • Echocardiography parameters, including ejection fraction, measures of right heart function, valve function

  • Peak VO2 consumption

  • Right heart catheterisation with assessment of cardiac index, right and left heart pressures

  • Heart Failure Survival Score

  • Seattle Heart Failure Model

  • Comorbidity profile, including respiratory status, liver and kidney function

  • Current or prior diagnosis of cancer

  • Current psychological status and prior psychological problems

  • Current HF treatment

  • Inotrope dependency

  • Repeated hospitalisations for congestion

  • NYHA class III–IV and

  • Intolerance to HF medication or

  • Hypotension or

  • Anaemia or

  • Deterioration of renal function or

  • Repeated HF hospitalisations

EF = ejection fraction; HF = heart failure; INTERMACS = Interagency Registry for Mechanically Assisted Circulatory Support; NT-proBNP = N-Terminal-pro brain natriuretic peptide; NYHA = New York Heart Association; VO2 = volume oxygen.